Implantable Cardiac Devices Market Set to Reach $18.8 Billion by 2029 with 8.7% Yearly Growth

What market dynamics are playing a key role in accelerating the growth of the implantable cardiac devices market?
The escalating occurrence of cardiovascular disorders is anticipated to boost the expansion of the implantable cardiac devices market. The surge in heart ailments can be credited to the rising prevalence of risk elements such as bad diet, inactive lifestyle, obesity, and persisting health conditions like diabetes and hypertension. Moreover, aging demography and growing stress levels also add up to the increasing occurrence of heart-related diseases. Implantable cardiac devices are employed to handle and treat conditions like heart failure, arrhythmias, and coronary artery disease. This mounting need prompts innovation and investment in the creation of new and advanced cardiac devices to cater to the expanding patient group and improve treatment results. For example, data from the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, indicate that ischemic heart disease caused 5,302 fatalities in May 2024, marking a minor rise from 5,290 fatalities in 2022. Consequently, the escalating occurrence of heart disorders fuels the expansion of the implantable cardiac devices market.

Get Your Implantable Cardiac Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-devices-global-market-report

How will the growth rate of the implantable cardiac devices market shape industry trends by 2034?
The market for implantable heart devices has seen significant expansion in the recent period. The market is projected to surge from a value of $12.34 billion in 2024 to $13.46 billion in 2025, translating to a compound annual growth rate (CAGR) of 9.1%. Elements that contributed to the growth during the historic period include tech advancements in the medical sector, an escalating occurrence of cardiovascular health issues, a burgeoning elderly population, betterment in device durability and dependability, increased consciousness and earlier detection of heart-related conditions.

Over the coming years, substantial expansion is anticipated in the implantable cardiac devices market, which is projected to reach $18.81 billion by 2029, registering a compound annual growth rate (CAGR) of 8.7%. Factors propelling this growth throughout the forecast period encompass advancements in device technology, a surge in demand for minimally invasive procedures, an escalating aging population, increased spending in healthcare, as well as, enhancements in healthcare infrastructure within emerging markets. The forecast period will also witness major trends such as digital health and remote monitoring integration, evolution of enhanced, next-generation devices, an acceleration in the adoption of personalized patient-specific cardiac solutions, a drive towards cost-efficiency and value in healthcare, alongside a growing emphasis on preventive cardiology and early intervention.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19097&type=smp

What trends are poised to drive the future success of the implantable cardiac devices market?
Primary companies in the implantable cardiac devices industry are concentrating on increasing compatibility with diagnostic tools like AutoMRI to extend the lifespan of devices and enhance patient safety. The AutoMRI feature in implantable cardiac defibrillators proactively alters the device settings to assure safe usage during MRI scans, thus improving patient care and enabling the use of modern imaging technology. As an example, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation leads to the Japanese market in October 2023. This innovative technology features low current consumption for increased device longevity and MRI compatibility. The ULYS ICD includes the PARAD+ arrhythmia discrimination algorithm and the AutoMRI functionality, whereas the INVICTA lead provides accurate pacing and defibrillation therapy, attaining a 100% successful implantation and 97.4% complication-free rate in clinical studies.

Which primary segments of the implantable cardiac devices market are driving growth and industry transformations?
The implantable cardiac devicesmarket covered in this report is segmented -

1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers
2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19097

Which geographical regions are pioneering growth in the implantable cardiac devices market?
North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the implantable cardiac devices market landscape?
Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19097&type=smp

What Is Covered In The Implantable Cardiac Devices Global Market Report?

•Market Size Forecast: Examine the implantable cardiac devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the implantable cardiac devices market for a structured understanding.
•Key Players Overview: Analyze major players in the implantable cardiac devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the implantable cardiac devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the implantable cardiac devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the implantable cardiac devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the implantable cardiac devices market.
•Competitive Landscape: Review strategic developments in the implantable cardiac devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.